Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma

Journal of Clinical Oncology

Volumn 25, Issue 29, 2007, Pages 4550-4556

  Heideman, Daniëlle A M ^a   Waterboer, Tim ^a   Pawlita, Michael ^a   Delis Van Diemen, Pien ^a   Nindl, Ingo ^a   Leijte, Joost A ^a   Bonfrer, Johannes M G ^a   Horenblas, Simon ^a   Meijer, Chris J L M ^a   Snijders, Peter J F ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6; PROTEIN E7; PROTEIN L1; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS DNA; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 12; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 17; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 20; HUMAN PAPILLOMAVIRUS TYPE 23; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 8; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; PENIS CARCINOMA; PRIORITY JOURNAL; SEROLOGY; SQUAMOUS CELL CARCINOMA; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, VIRAL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; GENOTYPE; GLOBINS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PAPILLOMAVIRUS INFECTIONS; PENILE NEOPLASMS;

EID: 35648988041     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.3182     Document Type: Article

References (33)

1. Parkin DM, Whelan SL, Ferlay J, et al: Cancer Incidence in Five Continents. Lyon, France, IARC Scientific Publication 155, 2002
2. Dillner J, von KG, Horenblas S, Meijer CJ: Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol 189-193, 2000 (suppl 2)
3. Daling JR, Madeleine MM, Johnson LG, et al: Penile cancer: Importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 116:606-616, 2005
4. Gross G, Pfister H: Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol (Berl) 193:35-44, 2004
5. Van Doornum GJ, Korse CM, Buning-Kager JC, et al: Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer 88:1095-1100, 2003
6. Carter JJ, Madeleine MM, Shera K, et al: Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res 61:1934-1940, 2001
7. Bjorge T, Dillner J, Anttila T, et al: Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ 315:646-649, 1997
8. Ferreux E, Lont AP, Horenblas S, et al: Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol 201:109-118, 2003
9. Rubin MA, Kleter B, Zhou M, et al: Detection and typing of human papillomavirus DNA in penile carcinoma: Evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 159:1211-1218, 2001
10. Levi JE, Rahal P, Sarkis AS, Villa L: Human papillomavirus DNA and p53 status in penile carcinomas. Int J Cancer 76:779-783, 1998
11. Cubilla AL, Velazques EF, Reuter VE, et al: Warty (condylomatous) squamous cell carcinoma of the penis: A report of 11 cases and proposed classification of 'verruciform' penile tumors. Am J Surg Pathol 24:505-512, 2000
12. Cubilla AL, Reuter VE, Gregoire L, et al: Basaloid squamous cell carcinoma: A distinctive human papilloma virus-related penile neoplasm - A report of 20 cases. Am J Surg Pathol 22:755-761, 1998
13. zur Hausen H: Papillomavirus infections: A major cause of human cancers. Biochim Biophys Acta 1288:F55-F78, 1996
14. Pagano JS, Blaser M, Buendia MA, et al: Infectious agents and cancer: Criteria for a causal relation. Semin Cancer Biol 14:453-471, 2004
15. de Villiers EM, Fauquet C, Broker TR, et al: Classification of papillomaviruses. Virology 324:17-27, 2004
16. Akgül B, Cooke JC, Storey A: HPV-associated skin disease. J Pathol 208:165-175, 2006
17. Wieland U, Jurk S, Weissenborn S, et al: Erythroplasia of Queyrat: Coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol 115:396-401, 2000
18. Lont AP, Kroon BK, Horenblas S, et al: Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer 119:1078-1081, 2006
19. Anders H-J, Rosenbauer J, Matiaske B: Repräsentative Verzehrstudie in der Bundesrepublik Deutschland incl. West-Berlin. Schriftenreihe der Arbeitsgemeinschaft Ernährungsverhalten, Umschau Verlag, Frankfurt am Main, 1990
20. Jacobs MV, Snijders PJ, van den Brule AJ, et al: A general primer GP5+-/GP6(+-)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 35:791-795, 1997
21. van den Brule AJ, Pol R, Fransen-Daalmeijer N, et al: GP5+-/6+- PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40:779-787, 2002
22. Brink AA, Lloveras B, Nindl I, et al: Development of a general-primer-PCR-reverse-line-blotting system for detection of beta and gamma cutaneous human papillomaviruses. J Clin Microbiol 43:5581-5587, 2005
23. Nindl I, Koehler A, Meyer T, et al: Detection of human papillomavirus DNA in primary squamous cell carcinoma and metastases. Br J Dermatol 154:797-799, 2006
24. Hesselink AT, van den Brule AJ, Groothuismink ZM, et al: Comparison of three different PCR methods for quantifying human papillomavirus type 16 DNA in cervical scrape specimens. J Clin Microbiol 43:4868-4871, 2005
25. Heideman DA, Snijders PJ, Bloemena E, et al: Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma. J Pathol 194:428-435, 2001
26. Seedorf K, Krammer G, Durst M, et al: Human papillomavirus type 16 DNA sequence. Virology 145:181-185, 1985
27. Dang C, Koehler A, Forschner T, et al: E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients. Br J Dermatol 155:129-136, 2006
28. Waterboer T, Sehr P, Michael KM, et al: Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 51:1845-1853, 2005
29. Karagas MR, Nelson HH, Sehr P, et al: Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 98:389-395, 2006
30. Dillner J: Toward "serolomics": Papillomavirus serology is taking a technologic lead in high-throughput multiplexed antibody analysis. Clin Chem 51:1768-1769, 2005
31. Dorfman S, Cavazza M, Cardozo J: Penile cancer associated with so-called low-risk human papilloma virus. Report of five cases from rural Venezuela. Trop Doct 36:232-233, 2006
32. Senba M, Kumatori A, Fujita S, et al: The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand. J Med Virol 78:1341-1346, 2006
33. Dillner J, Kallings I, Brihmer C, et al: Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis 173:1394-1398, 1996